Compugen Ltd. , a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe.
Compugen stock last closed at $1.64, down 1.2% from the previous day, and has decreased 20% in one year. It has overperformed other stocks in the Biotechnology industry by 0.56 percentage points. Compugen stock is currently +45.13% from its 52-week low of $1.13, and -38.35% from its 52-week high of $2.66.
There are currently 89.54M CGEN shares outstanding. The market capitalization of CGEN is $146.85M. In the past 24 hours, 174,000 CGEN shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy CGEN shares.
Based on our research, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen your brokerage, you need to fill out some personal info so you are able to invest in CGEN today.
Now that you have opened your account on app for stock market, you can securely and quickly fund your account:
Check out the tutorial below for more details transferring money into your brokerage account.
After you have identified the best place to buy Compugen stock, it's important to evaluate their stock prior to buying, so you can comprehend the risk and opportunity.
WallStreetZen was built to help average investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on CGEN's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge CGEN's true value.
Using relative valuations methods:
You can access more valuation analysis on CGEN's stock here.
You can dive deeper into what analysts are projecting on the Compugen stock forecast page.
Last year, CGEN revenue was $27.59M. Over the last four year, CGEN's revenue has gone up by 92.72% per year. This was faster than the Biotechnology industry average of 43.24%.
You can research CGEN's earnings and revenue performance here.
Over the last year, executives and large shareholders at CGEN have not bought or sold any shares.
Learn more about who owns CGEN shares here.
No, Compugen doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
You have two primary types of orders:
Press the Open button and your broker will place the order.
If you require more help buying stocks on eToro, click the helpful video below:
Now that you own some shares in CGEN, you'll want to keep up with your new investment.
Create a watchlist to get notified of important updates regarding your CGEN stock.
To reiterate, here are the 6 steps for buying Compugen stock:
If you need a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to track your new investment in Compugen, click below.